Healthtech Solutions (OTC: HLTT) has signed a contract to acquire a wholly owned subsidiary, Healthtech Oncology Inc., which will subsequently own a 100% interest in Varian Biopharmaceuticals Inc., a precision oncology company. Varian Bio is developing novel therapeutics for the treatment of cancer, including a proprietary atypical protein kinase C iota (“aPKCi”) inhibitor. Varian Bio’ has two lead drug candidates: VAR-101 (“VAR-101”) and VAR-102 (“VAR-102”); both drug candidates are in the pre-clinical research stage of development. HLTT’s investment in Varian aligns with its commitment to acquire and invest in cutting-edge healthcare technological companies. Precision oncology, which is when researchers and health care professionals utilize DNA testing to identify genetic mutations of unique tumors, may provide more targeted treatment recommendations designed to fight specific tumor types. In the announcement, Varian Bio noted that it has the support of leading oncology physicians and scientific institutions both in the United States and globally. “Varian Bio is at the leading edge of cancer treatment technology and it is an honor to have them join our portfolio,” said Healthtech Solutions chairman and CEO David Rubin in the press release. “The fact that they are developing therapies to target difficult-to-treat cancers such as pancreatic cancer demonstrates just how innovative their team is. Precision oncology is an exciting field and we’re thrilled to be a part of it.”
To view the full press release, visit https://nnw.fm/iodBr
About Healthtech Solutions Inc.
Healthtech Solutions, through its subsidiary Mediscan Inc., offers technology that can transform 2D images from a portable ultrasound machine into digital 3D images to provide better diagnosis and more accurate internal trauma views. The technology has multiple applications in lung, cardiac and musculoskeletal imaging and related uses. For more information, visit the company’s website at www.MyMediScan.com.
NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://nnw.fm/HLTT
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
